Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Numbers don't lie. As pmcb pps continues to crash the shares being sold a 50% market value will only intensify!!
And we're back to common sense....
Quote:
"No basis to this Just scare...tactics"
No? Then care to explain (logically) where the shares are going to come from for them to continue to sell in order to pay themselves? Outstanding shares increased 16% from 781,233,338 to 905,349,047
OUCH!!
$PMCB WARNING BUYER BEWARE
Reverse Split (R/S)
As of July 27, 2017, the registrant had 973,167,811 outstanding shares of common stock.
Common stock, authorized 1,490,000,000 shares, $0.0001 par value,
A Reverse Split (R/S) is a stock split that reduces the number of outstanding shares and increases the per-share price proportionately. For example, if a company declares a one-for-ten Reverse Split (R/S), then a ten cent stock will be worth $1.00 after the Reverse Split (R/S), but the number of shares held by investors will be reduced by a ratio of one share for each ten shares they held prior to the split. If one held 10,000 shares prior to the Reverse Split (R/S), they will hold 1,000 shares after the Reverse Split (R/S). While there are legitimate reasons to do a Reverse Split (R/S), more often than not, when a penny stock company does a Reverse Split (R/S) to its stock, it is bad news for investors in the stock. Unless, a penny stock company has an outstanding future with growing revenues, additional shares will likely be issued in the months and years after the Reverse Split (R/S), and the stock will eventually trade down sharply over time.
Oh and here is info on their clinical trials. Where's pmcb's?
https://clinicaltrials.gov/ct2/results?term=Diabetes+Research+Institute&type=&rslt=&age_v=&gndr=&cond=&intr=&titles=&outc=&spons=&lead=&id=&cntry1=&state1=&cntry2=&state2=&cntry3=&state3=&locn=&rcv_s=&rcv_e=&lup_s=&lup_e=#wrapper
https://www.diabetesresearch.org/diabetes-clinical-trials
Looks like pmcb isn't the only microencapsulation out there.
(DRI) DIABETES RESEARCH INSTITUTE
Islet Cell Encapsulation
Shrink-Wrapping Cells with Protective Coatings
When insulin-producing islet cells are transplanted into patients with diabetes, the immune system seeks to destroy the donor cells. But what if we could “hide” the transplanted islet cells from the immune system? Then we could prevent the risk of rejection from an immune attack.
For years, researchers have been trying to do just that -- to camouflage islets by encasing them in protective barriers. But these cell encapsulation strategies largely have failed, in part due to the size of the capsules and the materials used to encase the cells.
Now, new technology is providing the DRI with tools to improve cell encapsulation methods. Rather than the large, one-size-fits-all “bubble-like” capsules used elsewhere, DRI investigators have developed a system that creates a tight-fitting shield around each islet – as if they are individually “shrink-wrapping” each cell.
This “conformal” capsule? minimizes the space between the outer ?barrier of the capsule and the islet? within, making it easier for oxygen and other nutrients to reach the cell. This allows the cell to sense blood sugar and release insulin without the delay typical of previous capsules.
And, because there is little wasted space inside each capsule, the thousands of transplanted islets will take up less total space, offering researchers more options for implanting them within a BioHub. The DRI also is developing and testing a new technique to double-coat the islets to further protect and stabilize the encapsulated cells.
“Active” Coatings
Taking this promising encapsulation strategy a step further, researchers are developing ways to make the conformal coatings more “active.” They’re attaching special molecules to the surface that can help to decrease or eliminate inflammation and ward off an attack on the transplanted cells. The team is also incorporating oxygen promoters and other compounds within the coating materials to provide nutrients and additional protection.
Traditional microcapsules (left) leave empty space between the capsule barrier and the islet within, causing inefficient oxygen delivery to cells. The DRI is developing new protective coatings that fit tightly around an individual cell, like "shrink wrapping," which are more beneficial and can be used within a BioHub.
https://www.diabetesresearch.org/islet-cell-encapsulation
Nobody wants to partner with pmcb.
Look at Semma they had Novartis years before clinical trials were to be expected yet pmcb can't attract anyone except unsuspecting retail investors.
2014
What makes Semma Therapeutics Fierce: The startup expects that it is a few years from having an implant that's ready for clinical testing. In fact, a recent $44 million Series A round is slated to get it into human proof-of-concept testing. MPM Capital led the round with participation from Fidelity Biosciences, Arch Venture Partners and Medtronic ($MDT). Novartis ($NVS) also invested and became a partner, although no specifics about the deal have been disclosed.
"Semma had the ability to partner with almost any pharma that we wanted," said Semma CEO Robert Millman in an interview with FierceMedicalDevices. "We look at Novartis as being a very good partner. Other companies may have more at-risk in diabetes, but Novartis has made a commitment to cell and gene therapy from research through development." Millman expects Semma will be able to tap into some of Novartis' resources in that area.
http://www.fiercebiotech.com/special-report/semma-therapeutics
Let's post the whole story shall we?
Let's also pay attention to Semma as it's the only practical choice.
Emerging PC projects include projects which may begin human trials in the next two years. The projects listed below have received a significant amount of media coverage and represent the next-in-line PC projects. However, because none of these projects are currently testing in humans, they are likely more than [color=red] 15 years [/color away from FDA approval.
CELL TRANSPLANT WITH AUTOIMMUNE PROTECTION
Pharmacyte Biotech has begun testing its Cell-in-a-Box microencapsulation technology. Its insulin-producing Melligen cells, derived from liver cells, are being tested in mice. There is no current timeline for moving into clinical trials.
Orgenisis has developed a process to convert a patient’s liver cells into insulin-producing cells. Two clinical trials are scheduled to be performed in Germany and Belgium starting in 2017.
The DRI transplanted islet cells into the omentum in one human patient in an ongoing proof of concept phase I/II study.
Sernova is developing an encapsulation “pouch” the size of a credit card and containing donor islets. The company terminated a Phase I/II trial earlier this year.
Semma Therapeutics has commercialized Doug Melton’s work using stem cells to create beta cells. If successful, this work could be a key component of a Practical Cure. The project remains more than 24 months from starting human trials.
Strange that Austrianova sold the license to CIAB to pmcb when Austrianova can't produce the cell banks isn't it?
Pretty much make this statement bullshit them doesn't it?
We own 14% of the company which owns the best encapsulation technology in the world. It's unique. It's bioinert, retrievable, avoids fibrosis and can be frozen to allow distribution.
PMCB own IR statement makes that video a joke doesn't it?
Pmcb IR
"Thank you for your email and for your interest in PharmaCyte Biotech. Austrianova is not preparing the Master Cell Bank (MCB) or the Working Cell Bank (WCB) because this is not something that it does."
I never seen that one! That's hilarious as if being closer would help. Classic pmcb pump pr.
Sorry but no. Pmcb has $2m in payroll
But don't worry they still have 400m shares they can sell at .02-.03 cents to raise $.
Quote:
"We have enough to pay them. The company has over 2 million cash"
BULLSHIT not just part of this post or even 1/2 of it. It's 90% total bullshit written as if it were all proven and factual. Reality is it's of no fact, no verifiable evidence to back any of statements. Just ignorant pmcb propaganda.
To answer your question btw "Sound like a scam?"
YOU BETTCHA BUYER BEWARE.
Quote: "The encapsulation of cells is the next frontier in medicine, especially stem cells.
Any proof or are we going by what pmcb and those financially tied to pmcb say? Believing biased propaganda is quick way to go bankrupt.
We own 14% of the company which owns the best encapsulation technology in the world. It's unique. It's bioinert, retrievable, avoids fibrosis and can be frozen to allow distribution.
pmcb owns 14% of a private 2 man company worth ??? You/We will never know as long as it's private, congratulations on such a worthless investment pmcb. Sounds good to lure the unsuspecting in though doesn't it.
There's nothing else like it.
scam? Sure there are. Companies involved with or testing cell encapsulation? Again there are others as they've been posted here before.
Cell based treatments are the future and big pharmacyte knows this.
Do they? Is there a press release from any big pharma making any even just a fraction of this statement at all factual? Just a little?? Of course not I call Bullshit!
We have a way of directly attacking tumors right beside them and without side effects. Amazing
Says who? PMCB and CIAB creators Lohr, Salomns? Any credible / verifiable evidence to support any of these claims?? Or are we suppose to just believe?? After all it must be true if it was posted here that was written by pmcb and those affiliated! I'm sure those at pmcb are trying to sell me on their sales pitch or SHARES would never lie.... WTF
We have a way of putting insulin creating cells into the body to cure diabetes. Amazing
No shit?? Wow I had no idea pmcb has cured diabetes. Jeez shares at 06 cents and they've cured diabetes!! What a goldmine! (Cough cough) scam!!
We are creating our cell banks for a pivotal clinical trial in pancreatic cancer. Pivotal. Agreed by the FDA.
Who is creating them this week? We've waited over a year to get Austrianova gmp compliant (CGMP unconfirmed by FDA) now suddenly PMCB isn't using Austrianova? FDA didn't agree for "pivotal"! Again ignorant information. What the FDA did say is they would be willing to consider a pivotal one under the right circumstances.
We have an amazing team of world class doctors and oncologists involved and a consortium of the world's best advising the progress of our technology in cancer and diabetes.
Matter of ones personal opinion. If they're so great why did they have to change the trial at the last minute for the FDA? The whole FDA approval process should be a walk in the park for these Dr's if they're what some here believe.
Honestly, does this sound like a scam?
YES
Johnson and Johnson, novo nordisk and many diabetes organizations see cell encapsulation as the biggest hope for a cure for diabetes. The problem has been the immune system attacking those caps.
again any verifiable proof? A document from one of these mentioned? Anything? please!!!
Pharmacyte and ciab have the only solution to that which doesn't involve implants or surgery and all the problems associated with that.
WRONG
Of course big pharmacyte will want this? The question is how much will they pay and can kw salmon and gunzberg start a bidding war?"
of course? Hmm 20 years and no interested parties even for a low low wholesale cost of $2m! Nope just a crooked otc attorney of failed China-Tel Co scam seen something in CIAB. I wonder what that was....
Some may not like to hear what I have to say as it's mainly negative exposure of shady companies such as pmcb that are opposite of "bulls" illusions. I recommend buying and selling on ones own DD not what others say but I do suggest keeping an open mind and never let emotions cloud ones judgment. Btw nobody has ever lost money heeding my warnings and not buying into the bullshit being spewed by those intending to annihilate unsuspecting investors.
Haha they take raises no matter what.
Kw went from 50k in cash to 315k!!
530% increase in 3 years!!
How's pmcb shares doing
-70%
Carlos Trujillo annual $545,568
Annual Compensation*
Salary $245,251
Total Annual Compensation $245,251
Stock Options*
Restricted Stock Awards $131,120
Exercisable Options 10,200,000
Exercisable Options Value $71,520
Unexercisable Options 2,000,000
Total Value of Options $71,520
Total Number of Options 12,200,000
Total Compensation*
Total Annual Cash Compensation $245,251
Total Short Term Compensation $245,251
Other Long Term Compensation $131,120
Total Calculated Compensation
$545,568
Gerald Crabtree annual pay $364,809
Salary $144,000
Total Annual Compensation $144,000
Stock Options*
Restricted Stock Awards $68,780
Exercisable Options 18,700,000
Exercisable Options Value $71,520
Unexercisable Options 1,000,000
Total Value of Options $71,520
Total Number of Options 19,700,000
Total Compensation*
Total Annual Cash Compensation $144,000
Total Short Term Compensation $144,000
Other Long Term Compensation $68,780
Total Calculated Compensation
$364,809
The only one benefiting from pmcb is management who continuously hand themselves raises and meanwhile still haven't gotten CIAB into FDA trials as have been promised since 2013! Why should he? He's making a killing doing jack shit.
Here's Kenneth Waggoner annual pay!! Total annual $756,552
Salary $315,833
Total Annual Compensation $315,833
Stock Options*
Restricted Stock Awards $220,640
Exercisable Options 22,900,000
Exercisable Options Value $89,400
Unexercisable Options 3,000,000
Total Value of Options $89,400
Total Number of Options 25,900,000
Total Compensation*
Total Annual Cash Compensation $315,833
Total Short Term Compensation $315,833
Other Long Term Compensation $220,640
Total Calculated Compensation
756,552
So other words no verifiable and factual evidence from someone other than pmcb and their associates to back any of it up. Ok gotcha that's what thought.
I heard KW was seen at a bar discussing and comparing with Troy Convey on how many investors each has screwed over. Later that night apparently police issued a apb for 2 guys resembling dumb and dumber riding recklessly on a mini bike. Wow!
Quote:
"KW is working hard behind the scene for a bigger thing."
Ok best in the world right. Here's Austrianova Bloomberg snapshot. Notice the the 2 running this garbage?
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=252239727
You saw that too! Good eye. So ya I'm thinking the reverse split will be by the new year and will be a 10:1 split leaving investors with a fraction of what they currently have. What's your prediction?
Quote:
Like I said, the 10k showed things that were not mentioned in the PR that could have been PR worthy... to me this is a sign that he is gagged and can't say anything.
Funny I talked to my Dr last Friday about Dr's and boards during my yearly. He told me he gets requests all the time to join various boards. Company offer everything from their products to stocks, options and or even cash for permission to be able to list his name as a board member.
Go ahead and ask your doctor next time and he'll likely tell you the same.
I think many are misinformed, ignorant, and it desperate. Being a victim of a scam like pmcb tends to do that.
Quote:
"I think everyone had to sign NDAs and someone else other than Waggs is in control here"
Bullshit! what a joke
Quote;
"kw didn't post the fb comment about canadians if that wasn't true. he would be in big trouble if not.
Please inform us what laws has KW broke by making a comment on his personal FB about Canadians? Nothing said about pmcb. As much as I don't care for the guy this is just getting stupid now.
Wow I'm truly sorry for that. I'm equally sorry I wasn't able to convince some before such tragedies occurred.
Never bet it all especially on an OTC with shady management. I know it's to late now.
Quote:
"I have been here for about 1.5 years, When Dr. Von Hoff was first mentioned as being involved. I invested everything I could and I do have a time limit. At this point anger is keeping me motivated. I have nothing else to lose so things will get ugly if the money I worked hard for along with the money my father left me when he passed away was used to make other people rich. I gave my money to help this company, and I will get something back in return. I promise that.
How about the concern that pmcb continually sells shares at huge discounts ie. 50% in private transactions than the actual market value? That's a BIG SLAP IN THE FACE TO RETAIL INVESTORS!!
Quote:
"I'm just concerned about the 1 billion shares and no insider buying. And I'm quite certain that I'm not the only one on this board with these concerns."
Wow well that totally blows pmcb out of the water! That's great news for those with PC. Kick in the nads for those holding pmcb stock. We see now why Dr DVH has not shown interest in pmcb. He was working with a winner.
"Of the 24 evaluable patients (those whose response to a treatment could be measured because enough information was collected) who were enrolled in the study:
Eleven patients are still alive. The median overall survival rate of 16.5 months exceeds the historical average survival of six-12 months with standard chemotherapy.
Seventeen of 24 patients - 71 percent - had a reduction in tumor size of at least 30 percent.
Two of those 17 patients had a complete response - no detectable tumor.
This pilot clinical trial began in 2013 through a partnership between the HonorHealth Research Institute and TGen. It was funded by Stand Up To Cancer, Mattress Firm, the Arizona Diamondbacks, and the Scottsdale-based Seena Magowitz Foundation.
https://tgen.org/home/news/2017-media-releases/tgen-honorhealth-pancreatic-cancer-results.aspx#.WY-tOkFOmEd
Yes it is.
Quote:
"Old news....kaboom coming!"
You know what's older?
1. CIAB
2. CIAB 2 small past trials (1999)
3. Those behind pmcb that have been scamming investors not only since pmcb.
Do you realize any other "real" biotechs run up for many months before known or even speculated catalyst are supposed to take place?? I've seen toe nail fungus drug stocks run 100x higher on m/c than pmcb. The market has confirmed this to be what a few of us have been saying all along, a scam.
Quote:
waggs tells a group at ASCO that cell in box clinical trial for a pancreatic cancer unmet need will start during 4q of 2017...do you realize that is within a couple of months? All the noise about former employees won't matter when the IND application is approved by fda...look forward...kaboom is approaching....get ready or get left at the station.
Oh Snap!
Quote:
"How excited are you? 10 million shares excited?
Probably less than that at this point I bet."
On a side note I posted this awhile back.
Well that's NO GOOD!
I see PharmaCyte is still in bed with the corruption.
Joseph Fiore, Timothy Matula = Pump n Dump!
Timothy Matula
During his tenure as a public company executive, when Tim Matula is affiliated with an issuer there are two things that usually happen: the issuer is promoted by a combination of Stock Market Media Group and/or Cream Consulting and the stock value collapses. This is precisely what happened with Plandai Biotechnology, Inc. (OTCQB: OTCQB:OTCQB:PLPL) and LiveDeal, Inc. (NASDAQ: LIVE) and now history is repeating itself with SPYR, Inc.
Presently, Tim Matula is on the Board of Directors for LiveDeal, Inc. , another heavily promoted stock by Stock Market Media Group and Cream Consulting. The stock is down approximately 75% from its highs.
Whenever you see the trio of Tim Matula, Stock Market Media Group and Cream Consulting involved with a publicly-traded company, history tells us that you should run for the hills and this is one reason why we urge investors to be very cautious when trading SPYR, Inc.
https://www.linkedin.com/pulse/timothy-mark-matula-tim-matulabusiness-profile-public-relations?redirectFromSplash=true
Agree! Always leakers ask the Whitehouse. Now if ppl think pmcb has higher security, go right ahead and buy buy buy.
Quote:
"News imminent ?
If it were the pps and volume would be higher, not lower. You can't keep big news from leaking and buyers moving in. I believe we're months away from real action"
Why buy pmcb when they can buy cell in a box for $571.00
It's not like there are any patents protecting pmcb or Austrianova.
Yes it's all a big conspiracy lmao.
Big pharma is so scared of $69m pmcb, again lmfao. Is today national joke day?
Haha yet
Bought pmcb?
Believe KW?
Quote:
"Oh yes, I can recognize a liar a mile away."
Sooner than I thought. Austrianova end licensing deal with PharmaCyte.
Bavarian Nordic passed up a potential multi billion dollar treatment for low $ potential retroviral vector technology and poxvirus based delivery platform?? Ya ok. Bavarian Nordic knew NovaCaps now (CIAB) was garbage and wouldn't make it so like a real biotech they cut their losses and went on treatments that had potential.
Again common sense.
"The preclinical study, commissioned by Bavarian Nordic, used “targeted chemotherapy” to treat malignant ascites just as PharmaCyte biotech does. In the study, words like “complete tumor remission” and “cure” were used to describe the results, so why didn’t Bavarian Nordic continue on with its work?
Well, at the time of the study, Bavarian Nordic, the forerunner to Austrianova, had three in-house technologies: (i) the encapsulation technology; (ii) a retroviral vector technology; and (iii) a poxvirus based delivery platform. As a result of the attacks of 9/11 in the United States, Bavarian Nordic decided to focus strategically on the development of a smallpox vaccine based on its poxvirus platform and chose to divest the other two technologies, which eventually were moved into Austrianova."
Bavarian Nordic has been in multiple deals with JJ over the years. That's what happens when we're dealing with real biotechs with promising treatments.
Pmcb on the other hand has and will continue to fail. Giving examples of other companies and deals they've done is sad attempt to give false hope to those who have unfortunately bought into pmcb's bullshit. These other deals have absolutely nothing to do with a scams such as pmcb. Majority are well aware of this, hence the share price and low low volume.
Why? From what I'm reading HERE is pmcb already has a secret partner, getting bought out and even $30.00 share price coming! What nobody wants to buy on that spectacular news?
Or.
It's all bullshit and another failed attempt to attract investors to this pos so called biotech.
Quote:
"The miniscule volume proves there's NO accumulation by ANYBODY,
including the " longs " on this board."
Austrianova partner Pharmacyte Biotech's PMCB; (OTCMKTS) Chief Executive Officer, President, General Counsel and Chairman of the Board: Kenneth L. Waggoner has been seen returning from North Korea where an alleged meeting took place between himself and the Supreme leader Kim Jong un of the Democratic People's Republic of Korea (DPRK) regarding Pharmacyte Biotech's Cell in Box (CIAB) encapsulation technology device.
Pharmacyte Biotech's (CIAB) is an unproven encapsulation technology device that has yet to enroll in any US clinical trials therefore allowing it to pass through the latest sanctions placed upon the (DPRK). It has been reported that (CIAB) is regarded as the "miracle technology of the century" among Pharmacyte's internal management and its investors though only a few small studies were done nearly two decades ago. It's been speculated that (CIAB) can protect living cells placed inside the encapsulated cell from outside threats ranging anywhere from cancer to diabetes to now nuclear fallout and warfare.
It's been alleged that Pharmacyte Biotech along with its partner Austrianova is willing to give Mr. Kim Jong un a licensing agreement for the use of (CIAB) in combating and protection from nuclear fallout and warfare.
If joint agreement is reached Mr. Kim Jong un will pay Austrianova (a privately owned company) $1m usd and will receive 35% ownership of the company's restricted stock with options to purchase 500m shares of the company's common stock at a exercise cost of -50% of the value on the signing date with an expiration of five years.
Mr. Kim Jong un will pay Pharmacyte Biotech PMCB; (OTCMKTS) a sum of $25,000 usd in exchange for 25% ownership of the company's restricted stock and 300m shares of the companies common stock with options to purchase 300m shares of common stock at a exercise cost of .03 or closing market value reported by FINRA , whichever is less on the day of signing with an expiration of 5 years.
It's been reported that Mr. Waggoner is very pleased with the pending agreement and looks forward to working with Mr Kim Jong un and his regime. When it was asked why the (DPRK) would be interested in (CIAB)
It's been rumored that Mr. Kim Jong un has resorted to seeking (CIAB) technology in a last ditch effort that it will protect him from the Ass Kicking the U S A is about to bestow upon his ass and his regime."
The agreement is supposed to be reached by the 4th quarter of this year (2017) and if not then 4th quarter of 2018 or 2019,ect...
Further updates pending.
http://austrianova.com/mobile-home-gmp-cell-production-cmo-for-cell-therapy-manufacturing-1-1/index.html